Good News at Fred Hutch
September 29, 2017
Kyle Rybczyk is the clinic coordinator for the Vanderbilt HIV Vaccine Program, a unit of the HIV Vaccine Trials Network, or HVTN. Headquartered at Fred Hutch, HVTN is the world’s largest international collaboration focused on developing vaccines to prevent HIV/AIDS. It takes a global village to run a clinical trial like the AMP HIV Prevention Study underway now. Here is one villager’s story.
A performer and HIV advocate in Nashville, Tennessee, T.K. “Thunder Kellie” Hampton works for Street Works, an HIV services organization and a key partner of the Vanderbilt University unit of the Fred Hutch-based HIV Vaccine Trials Network. He recently appeared in a musical he wrote and directed, "YOU Shall LHiV 2 Zero," at the U.S. Conference on AIDS.
Will the flu vaccine work for you? Answer may be in your genes
August 31, 2017
New nanoparticles make targeted, temporary gene therapy possible
August 30, 2017
Scientists seeking a simple and gentle way to provide short-term gene therapy have a new tool: nanoparticles. In a paper published August 30 in Nature Communications, Dr. Matthias Stephan at Fred Hutchinson Cancer Research Center describes nanoparticles he has developed that can streamline the delivery of bundled genetic material to specific cells.
Looking for ‘a multitude of ways to cure HIV’
August 21, 2017
Pioneering CAR T-cell therapy researcher Dr. Carl June, director of the Center for Cellular Immunotherapies at the University of Pennsylvania's Perelman School of Medicine and a co-director of the Parker Institute for Cancer Immunotherapy, delivered the keynote address at the Conference on Cell and Gene Therapy for HIV Cure at Fred Hutch. To his right is gene therapy and stem cell transplant specialist Dr. Hans-Peter Kiem, co-director of the Fred Hutch-based defeatHIV.
University of Pennsylvania immunotherapy researcher Dr. Carl June, who led the development of an experimental therapy for advanced childhood leukemia that is expected to become the first CAR T-cell therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research Center.
As community engagement manager at the Vanderbilt HIV Vaccine Program, Sorrell gives talks like this many times. But even 36 years into the pandemic, HIV can make for a difficult conversation, one the 39-year-old Sorrell tailors to the audience and the moment, speaking from his heart and trusting he’ll strike the right chord.
Scared — and brave
June 14, 2017
How do people with HIV feel about volunteering for clinical trials testing experimental cures? If their responses could be summed up in one phrase, it would be the quote that Laurie Sylla chose for the title of her recent talk on the topic: “We’re scared … and brave.” Sylla is a member of the community advisory board for defeatHIV, based at Fred Hutchinson Cancer Research Center, one of six such research groups funded by the National Institutes of Health focused on curing the chronic viral infection.
Training tomorrow's HIV researchers
June 12, 2017
When Dr. Nishila Moodley took the stage to receive a special achievement award, 700 scientists, clinicians, outreach specialists and community members attending the annual meeting of the HIV Vaccine Trials Network — the largest global network working to develop and test a preventive HIV vaccine — cheered her accomplishment. They also celebrated the future of HIV vaccine research in South Africa.
eThekwini CAPRISA Research Clinic Site Profile
May 12, 2017
The Centre for the AIDS Programme of Research in South Africa(CAPRISA) conducts research that is globally relevant and locally responsive, contributing to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care. Collaboration with the HVTN to find a safe, effective HIV vaccine is integral to this work.
Dr. Glenda Gray among Time magazine’s ‘100 most influential’
April 20, 2017
Dr. Julie Overbaugh has long been committed to mentorship and graduate student training. These values have inspired the Fred Hutchinson Cancer Research Center HIV researcher and Human Biology Division member over the past year as she settled into the newly created role of Hutch Associate Director for Graduate Education.
'As Natives, it's what we do'
March 23, 2017
A Fred Hutch and University of Washington team of virologists and bioengineers led by Dr. Keith Jerome has received a $200,000 grant — the first phase of up to $1.5 million in milestone-driven funding over four years — to develop nanocarrier technology to deliver therapies to reservoirs of dormant, HIV-infected cells.
A decade has passed since the first of two stem cell transplants cured Brown of both leukemia and HIV, making him the first and so far only person to be cured of the virus that causes AIDS. Sunday’s “birthday” celebration, a tradition among transplant cancer survivors, capped a day-long workshop on HIV cure research on the eve of a major HIV scientific meeting, the annual Conference on Retroviruses and Opportunistic Infections, or CROI, being held in Seattle.
February 7, 2017
A decade after the first and so far only known HIV cure, researchers are hard at work to find a cure for many more.
It’s a tradition to celebrate the anniversary of a lifesaving bone marrow transplant as a rebirth. By that measure, today marks the 10th “birthday” of one of the world’s best known transplant survivors: Timothy Ray Brown.
Dr. Larry Corey: 35 Years in the AIDS Trenches
June 13, 2016
Today the founder and leader of the world’s largest HIV vaccine network, Corey will deliver a plenary talk on the state of HIV vaccine development at next month’s AIDS 2016 conference, the biannual meeting of the International AIDS Society, in Durban, South Africa. In August, he will be the keynote speaker at the third Conference on Cell and Gene Therapy for HIV cure at Fred Hutch about an even more challenging goal: an HIV cure.
Getting malaria on purpose
April 25, 2016
April 7, 2016
First Study to Evaluate Efficacy of Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection Among At Risk Populations
Super survivors: What those with HIV who don’t get sick can teach us
December 14, 2015
7 Myths About HIV and the Facts You Need to Know
November 17, 2015
Charlie Sheen reveals he’s HIV positive
November 17, 2015